Press release
Soft Tissue Sarcoma Pipeline, Clinical Trials Studies, Emerging Drugs, and FDA Approvals 2023 (Updated)
Soft Tissue Sarcoma Pipeline
Key Takeaways from the Soft Tissue Sarcoma Pipeline Report
• DelveInsight's Soft Tissue Sarcoma pipeline report depicts a robust space with 125+ active players working to develop 130+ pipeline therapies for Soft Tissue Sarcoma treatment.
• The leading companies working in the Soft Tissue Sarcoma Market include Advenchen Laboratories, Philogen, Gradalis, Epizyme, Chugai Pharma France, CytRx, Taiho Pharmaceuticals, KaryoPharm Therapeutics, Nanobiotix, Apexigen, Lytix Biopharma, Incyte Corporation, Iovance Biotherapeutics, Aadi Bioscience, Inc., AVEO Pharmaceuticals, Bayer, VasGene Therapeutics, Mirati Therapeutics, Novartis Pharmaceuticals, Tracon Pharmaceuticals, Jiangsu Hengrui Medicine, Exelixis, Qbiotics, AstraZeneca, Loxo Oncology, ImmunityBio, Monopar Therapeutics, Chipscreen Biosciences, Ltd., Agenus, C4 Therapeutics, Inc., Noxopharm Limited, and others.
• Promising Soft Tissue Sarcoma Pipeline Therapies in the various stages of development include Olaratumab, Pembrolizumab, NBTXR3, Glufosfamide, PXD101, and others.
• September 2023: Chipscreen Biosciences Ltd announced a study of phase 2 clinical trials for Chiauranib. This is a Phase 2, single-arm, open-label study in patients with advanced or unresectable soft tissue sarcoma.
• September 2023: Lyvgen Biopharma Holdings Limited announced a study of phase 1 & 2 clinical trials for LVGN6051 and Anlotinib. The purpose of this study is to asess the safety and tolerability and efficacy of LVGN6051 combined with anlotinib in patient with soft tissue sarcoma.
Request a sample and discover the recent advances in Soft Tissue Sarcoma Treatment Drugs @ Soft Tissue Sarcoma Pipeline Report- https://www.delveinsight.com/report-store/soft-tissue-sarcoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
In the Soft Tissue Sarcoma pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Soft Tissue Sarcoma collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Soft Tissue Sarcoma Overview
Soft tissue sarcoma is a disease in which malignant (cancer) cells form in the soft tissues of the body. Having certain inherited disorders can increase the risk of soft tissue sarcoma. A sign of soft tissue sarcoma is a lump or swelling in soft tissue of the body. Soft tissue sarcoma is diagnosed with a biopsy. Soft-tissue sarcomas are a group of cancers that begin in the connective tissues that support and connect the body, including: Blood vessels, Fat cells, Lining of joints, Lymph vessels, Muscle, Nerves and Tendons.
Find out more about Soft Tissue Sarcoma Therapeutics Assessment @ Soft Tissue Sarcoma Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/soft-tissue-sarcoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Soft Tissue Sarcoma Emerging Drugs Profile
• AL3818: Advenchen Laboratories
• L19 TNF: Philogen
• Camsirubicin: Monopar Therapeutics
Soft Tissue Sarcoma Pipeline Therapeutics Assessment
There are approx. 125+ key companies which are developing the Soft Tissue Sarcoma therapies. The Soft Tissue Sarcoma companies which have their Soft Tissue Sarcoma drug candidates in the most advanced stage, i.e. phase III include, Advenchen Laboratories, LLC.
Soft Tissue Sarcoma Pipeline Segmentation
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Soft Tissue Sarcoma Report Assessment
• Soft Tissue Sarcoma Pipeline Product Profiles
• Soft Tissue Sarcoma Therapeutic Assessment
• Soft Tissue Sarcoma Pipeline Assessment
• Inactive drugs assessment
• Soft Tissue Sarcoma Unmet Needs
Learn more about the emerging Soft Tissue Sarcoma Pipeline Therapies @ Soft Tissue Sarcoma Clinical Trials Assessment- https://www.delveinsight.com/sample-request/soft-tissue-sarcoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Soft Tissue Sarcoma Pipeline Report
• Coverage- Global
• Soft Tissue Sarcoma Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Soft Tissue Sarcoma Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Soft Tissue Sarcoma Companies- Advenchen Laboratories, Philogen, Gradalis, Epizyme, Chugai Pharma France, CytRx, Taiho Pharmaceuticals, KaryoPharm Therapeutics, Nanobiotix, Apexigen, Lytix Biopharma, Incyte Corporation, Iovance Biotherapeutics, Aadi Bioscience, Inc., AVEO Pharmaceuticals, Bayer, VasGene Therapeutics, Mirati Therapeutics, Novartis Pharmaceuticals, Tracon Pharmaceuticals, Jiangsu Hengrui Medicine, Exelixis, Qbiotics, AstraZeneca, Loxo Oncology, ImmunityBio, Monopar Therapeutics, Chipscreen Biosciences, Ltd., Agenus, C4 Therapeutics, Inc., Noxopharm Limited, and others.
• Soft Tissue Sarcoma Pipeline Therapies- Olaratumab, Pembrolizumab, NBTXR3, Glufosfamide, PXD101, and others.
Dive deep into rich insights for new drugs for Soft Tissue Sarcoma Treatment, Visit @ Soft Tissue Sarcoma Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/soft-tissue-sarcoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Soft Tissue Sarcoma: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Soft Tissue Sarcoma - DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Anlotinib: Advenchen Laboratories, LLC
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Camsirubicin: Monopar Therapeutics
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. FHD-609: Foghorn Therapeutics
15. Drug profiles in the detailed report…..
16. Inactive Products
17. Soft Tissue Sarcoma Key Companies
18. Soft Tissue Sarcoma Key Products
19. Soft Tissue Sarcoma- Unmet Needs
20. Soft Tissue Sarcoma- Market Drivers and Barriers
21. Soft Tissue Sarcoma- Future Perspectives and Conclusion
22. Soft Tissue Sarcoma Analyst Views
23. Soft Tissue Sarcoma Key Companies
24. Appendix
For further information on the Soft Tissue Sarcoma Pipeline therapeutics, reach out to Soft Tissue Sarcoma Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/soft-tissue-sarcoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting/ci-tracking
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Soft Tissue Sarcoma Pipeline, Clinical Trials Studies, Emerging Drugs, and FDA Approvals 2023 (Updated) here
News-ID: 3246914 • Views: …
More Releases from DelveInsight Business Research LLP
Chondrosarcoma Treatment Pipeline Shows Strong Momentum as 15+ Pharma Companies …
DelveInsight's "Chondrosarcoma Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Chondrosarcoma pipeline landscape. It covers the Chondrosarcoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chondrosarcoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Chondrosarcoma pipeline products in this space.
Explore our latest breakthroughs in Chondrosarcoma Research. Learn…
Fibrodysplasia Ossificans Progressiva Pipeline Drugs Insights Report 2025 | Delv …
DelveInsight's "Fibrodysplasia Ossificans Progressiva Pipeline Insight 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in the Fibrodysplasia Ossificans Progressiva pipeline landscape. It covers the Fibrodysplasia Ossificans Progressiva pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Fibrodysplasia Ossificans Progressiva pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Fibrodysplasia Ossificans Progressiva pipeline products…
Celiac Disease Clinical Trial Pipeline Gains Momentum: 25+ Companies Lead the Ch …
DelveInsight's, "Celiac Disease Pipeline Insight 2025" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Celiac Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Celiac Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay…
Chronic Periodontitis Clinical Trial Pipeline Appears Robust With 10+ Key Pharma …
DelveInsight's, "Chronic Periodontitis Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Chronic Periodontitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Download our comprehensive report now to explore clinical-stage developments and strategic…
More Releases for Soft
Soft Robotics Grippers Market 2026-2033: Key Trends, Opportunities, and Growth F …
The latest report titled "Soft Robotics Grippers Market" Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2033. offering a comprehensive and in-depth analysis of the industry. The report provides key insights into current market trends, growth drivers, challenges, and opportunities shaping the market landscape. It also includes a thorough competitor analysis, regional market evaluation, and recent technological or strategic developments influencing the market trajectory.
➤ Currently, the Soft Robotics Grippers Market holds…
Soft Robotic Gripper Market Size, Trends Analysis 2033 by Key Vendors- SoftGripp …
USA, New Jersey: According to Verified Market Reports analysis, the global Soft Robotic Gripper Market sizewas valued at USD 1.2 Billion in 2024 and is estimated to reach USD 5.7 Billion by 2033, growing at a CAGR of 18.6% from 2026 to 2033.
How AI and Machine Learning Are Redefining the Future of the Soft Robotic Gripper Market?
AI and machine learning are accelerating a new era of intelligent automation, enabling soft…
Soft Drink Concentrates Market
Introduction
The soft drink concentrates market plays a pivotal role in the global beverage industry. These concentrates are primarily used to prepare soft drinks, offering a cost-effective and efficient way for manufacturers to produce various beverages. Soft drink concentrates are essentially flavored syrups or powders that, when mixed with water or carbonated water, create popular soft drinks. The market for these concentrates has seen remarkable growth in recent years, driven by…
Soft Robot Technology Market Upcoming Trend & Positions 2027 | Cyberdyne, Soft R …
Soft Robot Technology Market Strengths, Weaknesses, Opportunities, and Threats analysis.
Demanding Market Research Report on Global Soft Robot Technology Market conducted by a team of industry specialists. The report covers briefly the products or services in the market and their application. The report also provides data on the technological advancements taking place in the Soft Robot Technology market, helping the market vendors to increase their business productivity and operational efficiency. The…
Soft Skills Management Market - Increasing Demand For Cloud-Based Soft Skill Tra …
According to a new market report published by Transparency Market Research, the global soft skills management market was valued at US$ 11,289.7 Mn in 2016 and is expected to expand at a CAGR of 11.9% from 2018 to 2026, reaching US$ 33,736.1 Mn by the end of the forecast period. According to the report, the global soft skills management market will continue to be influenced by a range of macroeconomic…
Suma Soft
Texas (USA), Canada (Toronto) & India (Business Network)— Suma Soft’s BPO for companies in USA, Canada and UK efficiently streamline business processes. Suma Soft has developed an integrated back-office system that assists these companies giving them round the clock support.
Credibility & Certification :
Suma Soft is an ISO 27001 and 9001 certified company which gives paramount importance to security, accuracy and quality while delivering BPO support services. We have a…
